Prolaris Pt.2 References

Quick Search


  1. D’Amico AV, Whittington R, Malkowicz B, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.  JAMA 1998; 280: 969-974.
  2. Thompson IM, Valicenti RK, Albertsen P, et al.  Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO guideline.  J Urol 2013; 190: 441-449.
  3. Parker C, Clarke N, Logue J, et al. RADICALS (radiotherapy and androgen deprivation in combination after local surgery).  Clin Oncol (R Coll Radiol) 2007; 19: 167-71.
  4. Cooperberg MR, Simko JP, Cowan JE, et al. Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort.  J Clin Oncol 2013; 31: 1428-34.
  5. Cuzick J, Swanson GP, Fisher G, et al. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.  Lancet Oncol 2011; 12: 245-55.
  6. Karnes J.R., Bergstralh EJ, Davicioni E, et al.  Validation of a genomic classifier that predicts metastasis following radical prostatectomy in at risk patient population.  J Urol 2013; 190: 2047-53.
  7. Cooperberg et al. AUA 2013 abstract.
  8. Kittaneh M, Montero AJ, Gluck S.  Molecular profiling for breast cancer: a comprehensive review.  Biomark Cancer 2013; 29: 61-70.

Related Posts: